|
ImmuCell Corporation - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for ImmuCell Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
ImmuCell Corporation. The Company's principal activity is to serve veterinarians and producers in the dairy and beef industries with innovative and proprietary products that improve animal health and productivity.Our lead product, First Defense(R) is manufactured from cows' colostrum using its proprietary vaccine and milk protein purification technologies. Mast Out(R), an intramammary infusion product containing Nisin, is being developed as an alternative to traditional antibiotics used in the treatment of mastitis in lactating dairy cows. The Company owns federal trademarks: First Defense(R), its calf scours preventive product, Wipe Out(R) Dairy Wipes and the related design and the trademark One Step Cow Prep(R), its pre-milking wipe product, MASTiK(R), antibiotic susceptibility test and Mast Out(R). In addition, the Company sells an animal health product under the trademark, rjtTM. The Company has customers in Canada, Australia, New Zealand and Europe.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
